The pharmacology of ketanserin, the first selective serotonin S₂‐antagonist

This publication has 57 references indexed in Scilit:

• Interaction of astemizole and other drugs with passive cutaneous anaphylactic and histamine‐, serotonin‐, and compound 48/80‐induced skin reactions in the rat: A Procedure to determine anti‐allergic effectiveness
  Drug Development Research, 1985
• Platelet-vessel wall interactions: Implication of 5-hydroxytryptamine. A review
  Inflammation Research, 1984
• Antagonism of the antidiarrhoeal effect of clonidine and the lethal effect of noradrenaline in rats: a reliable procedure to evaluate the in-vivo α1- and α2-blocking activity of drugs?
  Journal of Pharmacy and Pharmacology, 1984
• STUDIES ON THE MECHANISM OF ACTION OF THE HYPOTENSIVE EFFECT OF KETANSERIN
  Clinical and Experimental Pharmacology and Physiology, 1984
• Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin
  Nature, 1983
• Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade in spontaneously hypertensive rats.
  Hypertension, 1983
• The 5-hydroxytryptamine antagonist ketanserin inhibits the vasoconstrictor activity of per-operative CSF, from subarachnoid haemorrhage patients, on isolated tissues.
  Journal of Neurology, Neurosurgery & Psychiatry, 1983
• Hypotensive activity of serotonin antagonists; correlation with α1 -adrenoceptor and serotonin receptor blockade
  Life Sciences, 1983
• Inhibition of 5-hydroxytryptamine-induced and-amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT2-receptor antagonist
  Inflammation Research, 1982
• Receptor binding profile of R 41 468, A novel antagonist at 5-HT2 receptors
  Life Sciences, 1981